The Incruse Ellipta price is high because it’s a brand-name COPD maintenance inhaler that uses a long-acting anticholinergic ingredient for once-daily breathing control. Its proprietary delivery system and formulation drive up retail pricing. Prescription Bliss helps patients access official manufacturer programs that drop the cost to $49 per month.

The Incruse Ellipta cost with Medicare depends on your plan tier and deductible, but patients often still pay $100–$300 per month out of pocket. For those who don’t qualify for low-income subsidies or still pay too much, Prescription Bliss can help. We connect patients to manufacturer-backed programs that reduce the price to a flat $49 per month.

Yes. Prescription Bliss helps uninsured and self-pay patients qualify for verified assistance programs that make Incruse Ellipta affordable. Once approved, you’ll pay only $49 per month for one medication or $90 per month for two or more, and we handle all the paperwork, renewals, and refills for you.

Patients who are uninsured, under-insured, or paying high out-of-pocket costs may qualify for Incruse Ellipta assistance through Prescription Bliss. You’ll need a valid Incruse Ellipta prescription and to meet manufacturer income requirements. Once approved, your medication is shipped directly from the manufacturer.

Most patients begin receiving Incruse Ellipta within 2–3 weeks after approval. Prescription Bliss manages every step — from eligibility verification to renewals — so your treatment stays consistent and affordable.